Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharles Taylor Regulatory News (CTR)

  • There is currently no data for CTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Jul 2011 07:00

FOR IMMEDIATE RELEASE 1 July 2011

Charles Taylor Consulting plc

Board Changes

Charles Taylor Consulting plc (LON:CTR) ("CTC" or the "Company") is pleased to confirm that David Gideon Marock has been appointed to the board as Group Chief Executive Officer with effect from 1 July 2011.

There are no further details relating to the appointment of David Gideon Marock that are disclosable under paragraph 9.6.13 (1) to (6) of the Listing Rules of the UK Listing Authority.

As previously announced, John Stephen Martin Rowe resigned as Group Chief Executive Officer and from the board of the Company with effect from 30 June 2011.

For more information, please contact:

Rupert Robson, Chairman, +44 (0)07715 422535Charles Taylor Consultingplc Mike Lord, Group Communications Director, +44 (0)7831 401311Charles Taylor Consultingplc mike.lord@ctcplc.com NOTES TO EDITORS

About Charles Taylor Consulting

Charles Taylor Consulting is a leading provider of insurance services. We manage mutual insurance companies, advise insurers on complex insurance losses and provide administration and consultancy services to insurers and insureds worldwide. We also own life and non-life insurance companies which are closed to new business. Further information on the group can be found at www.charlestaylorconsulting.com.

David Marock background

* David Marock graduated from the University of Cape Town with a Bachelor's Degree in Business Science in 1992. He qualified as a fellow of the Faculty of Actuaries in 1995. * He joined Southern Life Association in 1992, following which he set up and led a business development team at Old Mutual Asset Managers in South Africa. * David Marock joined McKinsey & Co in 1999 where he advised numerous financial services groups, including insurers, banks and asset managers. * He joined Beazley in 2005 and led the Specialty Lines and Political Contingency Group Claims teams and the Private Enterprise Rest of World Underwriting team. * David Marock became the Group Chief Operating Officer of Beazley in 2008 and sat on the Group Executive Committee. He also chaired Beazley's European Group, sat on the Beazley Furlonge Limited Board and on a number of Group committees in the fields of investment, risk, regulation and growth initiatives.

XLON
Date   Source Headline
2nd Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20182:54 pmPRNTotal Voting Rights
17th Jan 20182:45 pmPRNDirector/PDMR Shareholding
2nd Jan 20188:00 amPRNTotal Voting Rights
22nd Dec 201710:35 amPRNBlocklisting - Interim Review
22nd Dec 20179:32 amPRNBlocklisting Application
8th Dec 20178:54 amPRNDirector/PDMR Shareholding
5th Dec 20177:52 amPRNTotal Voting Rights
17th Nov 20172:54 pmPRNDirector/PDMR Shareholding
14th Nov 20171:50 pmPRNDirector/PDMR Shareholding
3rd Nov 20174:20 pmPRNTotal Voting Rights
16th Oct 20178:21 amRNSAnnouncement of refinancing on improved terms
16th Oct 20177:00 amRNSCompletion of acquisition
3rd Oct 20179:43 amPRNTotal Voting Rights
6th Sep 20177:00 amRNSHalf Year Results
4th Sep 20177:00 amRNSAcquisition
1st Sep 20178:36 amPRNTotal Voting Rights
14th Aug 201712:40 pmPRNIssue of Equity
10th Aug 20177:00 amRNSAcquisition of Criterion Adjusters
7th Aug 201712:16 pmPRNHolding(s) in Company
1st Aug 20179:34 amPRNTotal Voting Rights
3rd Jul 20179:37 amPRNTotal Voting Rights
26th Jun 20177:00 amRNSCapital Markets Event
13th Jun 20177:00 amRNSDirectorate Change
8th Jun 201710:03 amPRNBlocklisting - Interim Review
2nd Jun 20173:05 pmPRNDirector/PDMR Shareholding
1st Jun 20179:35 amPRNTotal Voting Rights
19th May 201710:28 amPRNDirector/PDMR Shareholding
16th May 201711:14 amPRNResult of AGM
5th May 20177:27 amPRNDirector/PDMR Shareholding
2nd May 20177:38 amPRNIssue of Equity, Voting Rights and Share Capital
2nd May 20177:00 amRNSCompletion of acquisition
24th Apr 20173:31 pmPRNDirector/PDMR Shareholding
21st Apr 201710:43 amPRNDirector/PDMR Shareholding
18th Apr 20173:17 pmPRNAnnual Financial Report
13th Apr 20172:41 pmPRNDirector/PDMR Shareholding
10th Apr 20173:59 pmPRNHolding(s) in Company
10th Apr 20173:38 pmPRNHolding(s) in Company
10th Apr 20173:24 pmPRNDirector/PDMR Shareholding
3rd Apr 20179:34 amPRNTotal Voting Rights
22nd Mar 201710:46 amPRNDirector/PDMR Shareholding
17th Mar 20174:40 pmRNSSecond Price Monitoring Extn
17th Mar 20174:35 pmRNSPrice Monitoring Extension
13th Mar 201711:14 amPRNDirector/PDMR Shareholding
13th Mar 201711:09 amPRNDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
1st Mar 201710:00 amPRNTotal Voting Rights
23rd Feb 20173:50 pmPRNHolding(s) in Company
21st Feb 20179:54 amPRNAdditional Listing
10th Feb 201710:00 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.